Меню
Набор скоро начнётся NCT07563504

PROMab Trial: Ampicillin With or Without Gentamicin for Term Prelabour Rupture of Membranes

Фаза IV С лечением Rupture of Membranes Prior to Onset of Labor

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Ampicillin, Ampicillin + gentamicin.
Кому может быть актуально
Состояния в реестре: Rupture of Membranes Prior to Onset of Labor. Базовые параметры: от 18 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Малайзия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Term Prelabour Rupture of Membranes Antibiotic Prophylaxis (PROMab) Trial

Обзор

The goal of this clinical trial is to learn whether adding gentamicin to standard ampicillin prophylaxis can better prevent clinical chorioamnionitis and other maternal and neonatal infectious complications in pregnant women aged 18 years or older with singleton, cephalic, term pregnancies and confirmed prelabour rupture of membranes. The main questions it aims to answer are: Does ampicillin plus gentamicin reduce the incidence of clinical chorioamnionitis compared with ampicillin alone? Does ampicillin plus gentamicin improve maternal infectious outcomes and neonatal infection-related outcomes compared with ampicillin alone? Researchers will compare ampicillin alone with ampicillin plus gentamicin to see whether broader antibiotic coverage reduces maternal and neonatal infectious morbidity. Participants will: 1. undergo screening and eligibility assessment 2. provide written informed consent before randomisation 3. be randomly assigned to receive either intravenous ampicillin alone or intravenous ampicillin plus gentamicin 4. start study antibiotics at 12 hours after membrane rupture and continue treatment until delivery 5. undergo routine maternal and fetal monitoring during labour and delivery have maternal and neonatal outcomes assessed during hospital stay and up to 42 days postpartum, including telephone follow-up at Day 14 and Day 42 6. optionally consent to placental tissue collection for microbiological culture at delivery

Вмешательства

  • Препарат Ampicillin
    Intravenous ampicillin 2 g stat, followed by 1 g every 4 hours, initiated at 12 hours after prelabour rupture of membranes and continued until delivery.
  • Препарат Ampicillin + gentamicin
    Intravenous ampicillin 2 g stat, followed by intravenous ampicillin 1 g every 4 hours, plus intravenous gentamicin 5 mg/kg once daily. Study antibiotics will be initiated at 12 hours after prelabour rupture of membranes and continued until delivery. Gentamicin will only be administered to participants with baseline creatinine clearance of 30 mL/min or higher.

Первичные конечные точки

  • Clinical Chorioamnionitis [Срок оценки: From admission (diagnosis of PROM) until delivery (72 hours)]
Вторичные конечные точки (12)
  • Intrapartum Maternal Fever [Срок оценки: From admission (diagnosis of PROM) until delivery (72 hours)]
  • Postpartum Fever During Index Admission [Срок оценки: From admission (diagnosis of PROM) until delivery 7 days postpartum]
  • Early Postpartum Endometritis During Index Admission [Срок оценки: From admission (diagnosis of PROM) until delivery 7 days postpartum]
  • Peripartum Infection During Index Admission [Срок оценки: From admission (diagnosis of PROM) until delivery 7 days postpartum]
  • Postpartum Antibiotic Treatment Exceeding 24 Hours [Срок оценки: From admission (diagnosis of PROM) until delivery 7 days postpartum]
  • Puerperal Endometritis After Discharge [Срок оценки: From discharge until 42 days postpartum.]
  • Wound Infection [Срок оценки: From delivery until 42 days postpartum.]
  • Infection-related Hospitalisation Longer Than 5 Days or Readmission for Infection [Срок оценки: From delivery until 42 days postpartum.]
  • Culture-proven Early-onset Neonatal Sepsis [Срок оценки: Within the first 72 hours of life]
  • Neonatal Sepsis Evaluation [Срок оценки: From birth till 7 days of life]
  • NICU Admission [Срок оценки: From birth till 7 days of life]
  • Composite Neonatal Adverse Outcome [Срок оценки: From birth till 7 days of life]

Критерии участия

Критерии включения

  • Age 18 years or older
  • Singleton pregnancy
  • Cephalic (vertex) presentation
  • Term gestation of 37+0 weeks or more based on obstetric dating
  • Confirmed prelabour rupture of membranes
  • Duration of prelabour rupture of membranes 12 hours or less at the time of enrolment
  • Unknown or negative Group B Streptococcus status in the current pregnancy
  • Clear amniotic fluid at presentation
  • Afebrile with no clinical signs of intra-amniotic infection at admission
  • Able to provide written informed consent
  • Planned delivery at a participating study hospital

Критерии исключения

  • Preterm prelabour rupture of membranes before 37+0 weeks
  • Fever of 38.0°C or higher, maternal tachycardia, uterine tenderness, purulent discharge, or other clinical suspicion of infection at admission
  • Antibiotics already initiated in the current episode of care for any reason
  • Receipt of systemic antibiotics in the past 7 days
  • Meconium-stained liquor at presentation
  • Contraindication to vaginal delivery, including malpresentation, major placenta praevia, maternal refusal of trial of labour after caesarean, or known absolute indication for elective lower segment caesarean section
  • Known Group B Streptococcus colonisation in the current pregnancy, including positive rectovaginal swab or bacteriuria
  • Abnormal cardiotocography on admission requiring expedited delivery
  • Allergy or contraindication to penicillin or aminoglycosides
  • Renal impairment defined as creatinine clearance less than 30 mL/min
  • Known renal disease
  • Known ototoxicity risk or vestibular/cochlear disorders
  • Unknown timing of prelabour rupture of membranes
  • Multiple gestation
  • Major fetal anomaly

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Профилактика

Центры проведения

Малайзия · 3 центра
  • Sarawak General Hospital — Kuching
  • Miri Hospital — Miri
  • Sarikei Hospital — Sarikei

Публикации

  • Rutanen EM, Karkkainen TH, Lehtovirta J, Uotila JT, Hinkula MK, Hartikainen AL. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta. 1996 Sep 30;253(1-2):91-101. doi: 10.1016/0009-8981(96)80001-e. PMID 8879841
  • Abu Shqara R, Bussidan S, Glikman D, Rechnitzer H, Lowenstein L, Frank Wolf M. Clinical implications of uterine cultures obtained during urgent caesarean section. Aust N Z J Obstet Gynaecol. 2023 Jun;63(3):344-351. doi: 10.1111/ajo.13630. Epub 2022 Dec 4. PMID 36464667
  • Montelongo EM, Blue NR, Lee RH. Placenta Accreta in a Woman with Escherichia coli Chorioamnionitis with Intact Membranes. Case Rep Obstet Gynecol. 2015;2015:121864. doi: 10.1155/2015/121864. Epub 2015 Dec 27. PMID 26819787
  • Solomon S, Akeju O, Odumade OA, Ambachew R, Gebreyohannes Z, Van Wickle K, Abayneh M, Metaferia G, Carvalho MJ, Thomson K, Sands K, Walsh TR, Milton R, Goddard FGB, Bekele D, Chan GJ. Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. PLoS One. 2021 Aug 3;16(8):e0255410. doi: 10.1371/journal.pone.0255410. eCollection 2021. PMID 34343185
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053. No abstract available. PMID 24141714
  • Santschi EM, Papich MG. Pharmacokinetics of gentamicin in mares in late pregnancy and early lactation. J Vet Pharmacol Ther. 2000 Dec;23(6):359-63. doi: 10.1046/j.1365-2885.2000.00298.x. PMID 11168913
  • Gribomont AC, Stragier A. [Idiopathic epimacular membrane and vitreo-macular traction syndrome: vitrectomy functional results]. Bull Soc Belge Ophtalmol. 1996;262:123-6. French. PMID 9376915
  • Senat MV, Schmitz T, Bouchghoul H, Diguisto C, Girault A, Paysant S, Sibiude J, Lassel L, Sentilhes L. Term prelabor rupture of membranes: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). J Matern Fetal Neonatal Med. 2022 Aug;35(16):3105-3109. doi: 10.1080/14767058.2020.1810230. Epub 2020 Aug 27. PMID 32847438

Идентификаторы

NCT: NCT07563504 · PROMab-2026-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗